Add Yahoo as a preferred source to see more of our stories on Google. Four-year-old Jose Morales-Ortiz, with his guardian, Keith Joyce, is taking the drug leucovorin to help with this autism symptoms.

Name brand GLP-1 drugs like Ozempic and Wegovy have quickly become household names, akin to Tylenol or Advil, and their rise in popularity is only increasing. Originally developed to treat type 2 ...

As more continues to be understood about the health benefits associated with GLP-1 drugs, a growing body of science is aiming to answer whether the popular weight-loss medication can help with one of ...

Shortages and big price tags have driven patients to unconventional sources of GLP-1 drugs In late 2022, pharmacist Joseph Lambson got an unusual call from a poison control specialist. He said, “Hey ...

Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can ...

A baffling overdose death took investigators to the frontier of ultra-potent synthetic drugs. The clues were hauntingly ...

Researchers have solved the decades-old mystery behind how a common pregnancy drug lowers blood pressure. It turns out the medication blocks a fast-acting “oxygen alarm” inside cells. That same alarm ...

In December 2017, the FDA approved a new injectable drug to treat type 2 diabetes called semaglutide, which you likely know by its brand name: Ozempic. A few years later, during the pandemic, Wegovy, ...

GLP-1 medications like Ozempic have dominated headlines over the past couple of years. When writing his new book, Diet, Drugs and Dopamine: The New Science of Achieving a Healthy Weight, former FDA ...

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. Over the past few years GLP-1 drugs have gone from relatively obscure diabetes ...

The route a drug takes into the body can matter as much as the drug itself – and rectal use brings risks that are rarely talked about openly. In health settings, this route is familiar through ...